drugset

drugset / Trial / NCT07329101

Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis

NCT07329101 ↗

Phase 1 Completed 11 enrolled Jiangsu vcare pharmaceutical technology co., LTD

NaSingle-groupOpen-labelTreatment

Summary

This is a single arm, and open-label phase I study

Timeline

Start: 2025-11-11
Primary completion: 2026-02-06
Completion: 2026-02-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VC005	Unknown	—	Topical

Indications